Niu et al., 2019 - Google Patents
MiRNA-221-5p promotes breast cancer progression by regulating E-cadherin expression.Niu et al., 2019
View PDF- Document ID
- 12715483142274746072
- Author
- Niu X
- Zhang Z
- Ma P
- Publication year
- Publication venue
- European Review for Medical & Pharmacological Sciences
External Links
Snippet
OBJECTIVE: To elucidate the role of miRNA-221-5p in the development of breast cancer (BCa) and its underlying mechanism. PATIENTS AND METHODS: The expression level of miRNA-221-5p in 52 pairs of BCa tissues and adjacent normal tissues was detected by …
- 206010006187 Breast cancer 0 title abstract description 100
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2 | |
| Yang et al. | TMEM64 aggravates the malignant phenotype of glioma by activating the Wnt/β-catenin signaling pathway | |
| Zhang et al. | microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN | |
| Shi et al. | Downregulated lncRNA ADAMTS9-AS2 in breast cancer enhances tamoxifen resistance by activating microRNA-130a-5p. | |
| Ke et al. | MiR-1-3p suppresses cell proliferation and invasion and targets STC2 in gastric cancer. | |
| Guo et al. | MiR-135a-5p represses proliferation of HNSCC by targeting HOXA10 | |
| Niu et al. | MiRNA-221-5p promotes breast cancer progression by regulating E-cadherin expression. | |
| Wang et al. | Role of lncRNAHCP5/microRNA-525–5p/PRC1 crosstalk in the malignant behaviors of ovarian cancer cells | |
| Xue et al. | MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2. | |
| Zhang et al. | HOTAIR maintains the stemness of ovarian cancer stem cells via the miR-206/TBX3 axis | |
| Zhou et al. | TRIP13 promotes proliferation and invasion of epithelial ovarian cancer cells through Notch signaling pathway. | |
| Peng et al. | LncRNA PSMA3-AS1 promotes colorectal cancer cell migration and invasion via regulating miR-4429. | |
| Xia et al. | MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1. | |
| Liao et al. | USP3 promotes proliferation of non-small cell lung cancer through regulating RBM4. | |
| Li et al. | Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma | |
| Huang et al. | IMP3 promotes TNBC stem cell property through miRNA-34a regulation. | |
| Xu et al. | LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis. | |
| Sun et al. | MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma | |
| Zeng et al. | CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1. | |
| Wang et al. | LncRNA SNHG14 promotes proliferation of endometrial cancer through regulating microRNA-655-3p. | |
| Zhang et al. | MiRNA-621 inhibits the malignant progression of non-small cell lung cancer via targeting SIX4. | |
| Chen et al. | MiRNA-206 inhibits proliferation of renal clear cell carcinoma by targeting ZEB2. | |
| Zhou et al. | Expression and clinical significance of long-non-coding RNA GHET1 in pancreatic cancer. | |
| Hu et al. | Long non-coding RNA LINC00173 serves as sponge for miR-338-3p to promote prostate cancer progression via regulating Rab25. | |
| Xu et al. | MiR-650 inhibits the progression of glioma by targeting FAM83F. |